000 01570 a2200433 4500
005 20250516094102.0
264 0 _c20121211
008 201212s 0 0 eng d
022 _a1872-6623
024 7 _a10.1016/j.pain.2012.04.016
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aThibault, Karine
245 0 0 _aCortical effect of oxaliplatin associated with sustained neuropathic pain: exacerbation of cortical activity and down-regulation of potassium channel expression in somatosensory cortex.
_h[electronic resource]
260 _bPain
_cAug 2012
300 _a1636-1647 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
650 0 4 _aChronic Pain
_xchemically induced
650 0 4 _aDown-Regulation
_xdrug effects
650 0 4 _aMale
650 0 4 _aNeuralgia
650 0 4 _aNeuronal Plasticity
_xdrug effects
650 0 4 _aOrganoplatinum Compounds
650 0 4 _aOxaliplatin
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aShab Potassium Channels
_xmetabolism
650 0 4 _aSomatosensory Cortex
_xdrug effects
650 0 4 _aTissue Distribution
_xdrug effects
700 1 _aCalvino, Bernard
700 1 _aDubacq, Sophie
700 1 _aRoualle-de-Rouville, Marie
700 1 _aSordoillet, Vallier
700 1 _aRivals, Isabelle
700 1 _aPezet, Sophie
773 0 _tPain
_gvol. 153
_gno. 8
_gp. 1636-1647
856 4 0 _uhttps://doi.org/10.1016/j.pain.2012.04.016
_zAvailable from publisher's website
999 _c21826229
_d21826229